CD19, a B-cell surface protein ... antibody affinity measurement and detection of anti-CD19 CAR expression. The high activity of such proteins has been confirmed by ELISA, SPR and flow cytometry ...

ImmunityBio has announced the commencement of a Phase I clinical trial evaluating its CD19 targeted high-affinity ... The CD19-t-haNK cell therapy uses a stable clonal NK cell line derived from ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...